Galapagos receives transparency notification from FMR LLC
August 29 2022 - 3:01PM
Galapagos receives transparency notification from FMR LLC
Mechelen, Belgium; 29
August 2022,
22.01
CET; regulated information – Galapagos NV
(Euronext & NASDAQ: GLPG) received a
transparency notification from FMR LLC.
Pursuant to Belgian transparency legislation1,
Galapagos received a transparency notification on 25 August 2022
from FMR LLC, who notified that it holds 3,710,782 of Galapagos’
voting rights, consisting of 3,710,782 ordinary shares. FMR LLC
controls investment funds Fidelity Management & Research
Company LLC, FIAM Holdings LLC, Fidelity Management Trust Company
and Strategic Advisers LLC, of which Fidelity Management &
Research Company LLC decreased its position to 3,272,828 voting
rights, and Strategic Advisers LLC increased its position to 10,322
voting rights. Hence, the first-mentioned controlled undertaking of
the FMR LLC group individually crossed below the 5% threshold. FMR
LLC's holding of 3,710,782 Galapagos' voting rights, including its
controlled undertakings’ holdings, represents 5.65% of Galapagos'
currently outstanding 65,728,511 shares. FMR LLC thus remains above
the 5% threshold of Galapagos’ voting rights. The full transparency
notice is available on the Galapagos website.
About
GalapagosGalapagos is a fully integrated biotechnology
company focused on discovering, developing, and commercializing
innovative medicines. We are committed to improving patients’ lives
worldwide by targeting diseases with high unmet needs. Our R&D
capabilities cover multiple drug modalities, including small
molecules and cell therapies. Our portfolio comprises discovery
through to Phase 3 programs in inflammation, oncology, fibrosis,
and other indications. Our first medicine for rheumatoid arthritis
and ulcerative colitis is approved and available in the European
Union (including Norway), Great Britain and Japan. For additional
information, please visit www.glpg.com or follow us on LinkedIn or
Twitter.
ContactInvestors:Sofie
Van GijselHead of Investor Relations+1 781 296 1143
Sandra CauwenberghsDirector Investor Relations+32 495 58 46
63ir@glpg.com
Media:Marieke VermeerschHead of Corporate
Communication+32 479 490 603media@glpg.com
1 Belgian Act of 2 May 2007 on the disclosure of major
shareholdings in issuers whose shares are admitted to trading on a
regulated market
Galapagos (TG:GXE)
Historical Stock Chart
From Aug 2024 to Sep 2024
Galapagos (TG:GXE)
Historical Stock Chart
From Sep 2023 to Sep 2024